Join us for an insightful webinar on navigating the recent FDA updates as pharma and cosmetics companies, featuring experts Herman Lelie, PhD, and Jonathan Vaught, PhD. The experts will analyze the latest FDA regulatory updates affecting drug development and explore the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
Available on demand
Learning Objectives
- Overview of recent FDA regulatory updates in drug development
- Implications of MoCRA for cosmetics companies
- Strategies for small businesses to manage compliance challenges
- Importance of quality systems and GxP environments
- Benefits of strategic partnerships for regulatory success
This session is tailored for companies seeking sustainable compliance solutions, offering critical insights into the increased scrutiny for safety and the compliance challenges small businesses continue to face.
By the end of this session, attendees will learn effective planning strategies and the importance of partnerships to navigate these regulations successfully.
Looking to Connect with the Speakers?
Got questions for the speakers after watching the webinar?
Talk to the guest speakers, Herman Lelie, PhD, and Jonathan (Jon) Vaught, PhD, and send your question their way. Herman and Jon are happy to answer them!
